Documents
Christopher Ambrose
Christopher Ambrose, MD, MBA
Franchise Head, US BioPharmaceuticals
at
AstraZeneca
MD,
US
Send Message 
Add Friend 
Remove Friend 
Block User 
Invite to Group 
Report User | Date Uploaded | Name | Description | File |
|---|---|---|---|
| 2022-12-16 13:09PM | Chipps et al Remission MS_16Dec22.pdf | chipps_et_al_remission_ms_16dec22.pdf | |
| 2022-12-09 15:49PM | Clinical Remission With Biologic Use Among US Subspecialist-Treated Patients With Severe Asthma: Results From the CHRONICLE Study | Revised manuscript | remission_ms_revised_final.pptx |